IBIO, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
IBIO, INC. (IBIO) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-05-12
- IBIO, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2025-09-30 was 0.00%.
- IBIO, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-09-30 was 0.00%.
- IBIO, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2023-09-30 was 0.00%.
- IBIO, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2022-09-30 was 0.00%.
- IBIO, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2025 was 0.00%.
- IBIO, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.00%.
- IBIO, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
- IBIO, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|
| 2026-03-31 | 0.00% 10-Q · filed 2026-05-12 | |||
| 2025-12-31 | 0.00% 10-Q · filed 2026-02-10 | |||
| 2025-09-30 | 0.00% 10-Q/A · filed 2025-11-17 | |||
| 2025-06-30 | 0.00% 10-K · filed 2025-09-05 | |||
| 2025-03-31 | 0.00% 10-Q · filed 2025-05-02 | |||
| 2024-12-31 | 0.00% 10-Q · filed 2025-02-10 | |||
| 2024-09-30 | 0.00% 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | 0.00% 10-K/A · filed 2024-09-24 | |||
| 2024-03-31 | 0.00% 10-Q · filed 2024-05-13 | |||
| 2023-12-31 | 0.00% 10-Q · filed 2024-02-09 | |||
| 2023-09-30 | 0.00% 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | 0.00% 10-K/A · filed 2024-09-24 | |||
| 2023-03-31 | 0.00% 10-Q · filed 2023-05-15 | |||
| 2022-12-31 | 0.00% 10-Q/A · filed 2023-05-19 | |||
| 2022-09-30 | 0.00% 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | 0.00% 10-K · filed 2023-09-27 | |||
| 2022-03-31 | 0.00% 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | 0.00% 10-Q · filed 2022-02-14 | |||
| 2021-09-30 | 0.00% 10-Q · filed 2021-11-15 | |||
| 2021-06-30 | 0.00% 10-K · filed 2022-10-11 | |||
| 2021-03-31 | 0.00% 10-Q · filed 2021-05-17 | |||
| 2020-12-31 | 0.00% 10-Q · filed 2021-02-16 | |||
| 2020-09-30 | 0.00% 10-Q · filed 2020-11-16 | |||
| 2020-06-30 | 0.00% 10-K · filed 2021-09-28 | |||
| 2020-03-31 | 0.00% 10-Q · filed 2020-05-15 | |||
| 2019-12-31 | 0.00% 10-Q · filed 2020-02-14 | |||
| 2019-09-30 | 0.00% 10-Q · filed 2019-11-14 | |||
| 2019-06-30 | 0.00% 10-K · filed 2020-10-13 | |||
| 2018-06-30 | 0.00% 10-K · filed 2019-08-26 | |||
| 2018-03-31 | 0.00% 10-Q · filed 2018-05-11 | |||
| 2017-12-31 | 0.00% 10-Q · filed 2018-02-14 | |||
| 2017-09-30 | 0.00% 10-Q · filed 2017-11-09 | |||
| 2017-06-30 | 0.00% 10-K · filed 2018-09-18 | |||
| 2017-03-31 | 0.00% 10-Q · filed 2017-05-15 | |||
| 2016-06-30 | 0.00% 10-K · filed 2017-09-15 | |||
| 2016-03-31 | 0.00% 10-Q · filed 2016-05-23 | |||
| 2015-12-31 | 0.00% 10-Q · filed 2016-02-22 | |||
| 2015-09-30 | 0.00% 10-Q · filed 2015-11-13 | |||
| 2015-06-30 | 0.00% 10-K · filed 2016-10-13 | |||
| 2015-03-31 | 0.00% 10-Q · filed 2015-05-15 | |||
| 2014-12-31 | 0.00% 10-Q · filed 2015-02-24 | |||
| 2014-09-30 | 0.00% 10-Q · filed 2014-11-14 | |||
| 2014-06-30 | 0.00% 10-K · filed 2015-10-13 | |||
| 2013-06-30 | 0.00% 10-K · filed 2014-09-29 | |||
| 2012-06-30 | 0.00% 10-K/A · filed 2013-10-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |